Administration of appropriate anticoagulant, antiplatelet and coronary vasodilator therapy is critical to successful stent implantation and follow-up. Judicious selection of patients is necessary since the use of this device carries the associated risk of subacute thrombosis, vascular complications and/or bleeding events.Patients who are judged to have a lesion that prevents complete inflation of an angioplasty balloon.Patients in whom antiplatelet and/or anticoagulation therapy is contraindicated.The Medtronic Driver Coronary Stent Systems are indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo or restenotic lesions with reference vessel diameters of 3.0 mm to 4.0 mm and ≤30 mm in length using direct stenting or predilatation.
Indications, Safety & Warnings Intended Use
0 kommentar(er)
